|
DE75755C
(de)
|
|
1894-06-14 |
DAHL & COMP, in Barmen |
Verfahren zur Darstellung von aromatisch substituirten Amidodinaphtylmethanen.
|
|
DE3132020A1
(de)
*
|
1981-08-13 |
1983-03-03 |
Basf Ag, 6700 Ludwigshafen |
N-benzoyl-n'-phenylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von insekten und spinnentieren
|
|
IT1227260B
(it)
|
1988-09-30 |
1991-03-28 |
Himont Inc |
Dieteri utilizzabili nella preparazione di catalizzatori ziegler-natta
|
|
AU7044994A
(en)
|
1993-05-24 |
1994-12-20 |
Nycomed Pharma |
Hemoregulatory peptides
|
|
US5683999A
(en)
|
1995-03-17 |
1997-11-04 |
The Dupont Merck Pharmaceutical Company |
Cyclic urea HIV protease inhibitors
|
|
SI9500173B
(sl)
|
1995-05-19 |
2002-02-28 |
Lek, |
Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo
|
|
US6037157A
(en)
|
1995-06-29 |
2000-03-14 |
Abbott Laboratories |
Method for improving pharmacokinetics
|
|
US5935982A
(en)
|
1997-02-28 |
1999-08-10 |
The University Of North Carolina At Chapel Hill |
Methods of treating retroviral infection and compounds useful therefor
|
|
US6235493B1
(en)
|
1997-08-06 |
2001-05-22 |
The Regents Of The University Of California |
Amino acid substituted-cresyl violet, synthetic fluorogenic substrates for the analysis of agents in individual in vivo cells or tissue
|
|
US6911462B2
(en)
|
1998-05-22 |
2005-06-28 |
Avanir Pharmaceuticals |
Benzimidazole compounds for regulating IgE
|
|
US6369091B1
(en)
|
1998-05-22 |
2002-04-09 |
Avanir Pharmaceuticals |
Benzimidazole analogs as down-regulators of IgE
|
|
US6919366B2
(en)
|
1998-05-22 |
2005-07-19 |
Avanir Pharmaceuticals |
Benzimidazole derivatives as modulators of IgE
|
|
WO1999061013A2
(en)
|
1998-05-22 |
1999-12-02 |
Avanir Pharmaceuticals |
COMPOUNDS HAVING IgE AFFECTING PROPERTIES
|
|
KR100336090B1
(ko)
|
1998-06-27 |
2002-05-27 |
윤승원 |
오일, 지방산 또는 이들의 혼합물을 함유한 난용성 약물의 고형분산제제
|
|
US6387885B1
(en)
|
1998-08-26 |
2002-05-14 |
Abbott Laboratories |
3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
DE19913692A1
(de)
|
1999-03-25 |
2000-09-28 |
Basf Ag |
Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
|
|
CA2395520A1
(en)
|
1999-12-21 |
2001-06-28 |
Sugen, Inc. |
4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
|
|
JP4748911B2
(ja)
|
2000-04-05 |
2011-08-17 |
シェーリング コーポレイション |
Ｎ−環状ｐ２部分を含むｃ型肝炎ウイルスの大環状ｎｓ３‐セリンプロテアーゼ阻害剤
|
|
DE10026698A1
(de)
|
2000-05-30 |
2001-12-06 |
Basf Ag |
Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
|
|
US7065453B1
(en)
|
2000-06-15 |
2006-06-20 |
Accelrys Software, Inc. |
Molecular docking technique for screening of combinatorial libraries
|
|
AU2001281255B2
(en)
|
2000-08-14 |
2006-07-20 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted pyrazoles
|
|
US6388093B1
(en)
|
2001-01-05 |
2002-05-14 |
Sun Chemical Corporation |
Syntheses for preparing 1,4-diketopyrrolo [3,4-c]pyrroles
|
|
AU2002344854B2
(en)
|
2001-06-11 |
2008-11-06 |
Vertex Pharmaceuticals (Canada) Incorporated |
Thiophene derivatives as antiviral agents for flavivirus infection
|
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
|
RU2286343C2
(ru)
|
2001-08-10 |
2006-10-27 |
Орто-Макнейл Фармасьютикал, Инк. |
Замещенные пиразолы
|
|
AU2003216274A1
(en)
|
2002-02-11 |
2003-09-04 |
Neurocrine Biosciences, Inc. |
Pyrrole derivatives as ligands of melanocortin receptors
|
|
JP3925265B2
(ja)
|
2002-03-25 |
2007-06-06 |
コニカミノルタホールディングス株式会社 |
有機エレクトロルミネッセンス素子及びそれを用いた表示装置
|
|
TW200304820A
(en)
|
2002-03-25 |
2003-10-16 |
Avanir Pharmaceuticals |
Use of benzimidazole analogs in the treatment of cell proliferation
|
|
KR20050010515A
(ko)
|
2002-06-14 |
2005-01-27 |
머크 앤드 캄파니 인코포레이티드 |
유사분열 키네신 억제제
|
|
EP1554269A1
(en)
|
2002-07-09 |
2005-07-20 |
Vertex Pharmaceuticals Incorporated |
Imidazoles, oxazoles and thiazoles with protein kinase inhibiting activities
|
|
WO2004014852A2
(en)
|
2002-08-12 |
2004-02-19 |
Bristol-Myers Squibb Company |
Iminothiazolidinones as inhibitors of hcv replication
|
|
KR100482276B1
(ko)
*
|
2002-08-12 |
2005-04-13 |
한국과학기술연구원 |
피롤계 화합물, 그 중합체 및 이들을 이용한 ｅｌ 소자
|
|
GB0229518D0
(en)
|
2002-12-19 |
2003-01-22 |
Astrazeneca Ab |
Chemical compounds
|
|
TW200508224A
(en)
|
2003-02-12 |
2005-03-01 |
Bristol Myers Squibb Co |
Cyclic derivatives as modulators of chemokine receptor activity
|
|
JP4810427B2
(ja)
*
|
2003-05-22 |
2011-11-09 |
アボット・ラボラトリーズ |
インダゾール、ベンズイソオキサゾールおよびベンズイソチアゾールキナーゼ阻害剤
|
|
US8025899B2
(en)
|
2003-08-28 |
2011-09-27 |
Abbott Laboratories |
Solid pharmaceutical dosage form
|
|
EP1670415A4
(en)
|
2003-09-12 |
2007-12-05 |
Vertex Pharma |
ANIMAL MODEL FOR STUDYING PROTEASES ACTIVITY AND HEPATIC DISORDERS
|
|
EP1677827B1
(en)
|
2003-10-27 |
2008-12-10 |
Vertex Pharmaceuticals Incorporated |
Combinations for hcv treatment
|
|
UY28758A1
(es)
*
|
2004-02-20 |
2005-09-30 |
Boehringer Ingelheim Int |
Inhibidores de polimerasa viral
|
|
BRPI0401908A
(pt)
|
2004-06-04 |
2006-01-17 |
Univ Rio De Janeiro |
Compostos inibidores de serina protease, processo de obtenção e uso para tratamento de flaviviroses
|
|
US7772271B2
(en)
|
2004-07-14 |
2010-08-10 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
BRPI0513811A
(pt)
|
2004-07-27 |
2008-07-15 |
Gilead Sciences Inc |
imidazo [4,5-d] pirimidinas, seus usos e processos de preparação
|
|
AU2005272619A1
(en)
|
2004-08-13 |
2006-02-23 |
Praecis Pharmaceuticals, Inc. |
Methods and compositions for modulating sphingosine-1-phosphate (SIP) receptor activity
|
|
CN101027291A
(zh)
*
|
2004-09-24 |
2007-08-29 |
阿斯利康(瑞典)有限公司 |
苯并咪唑衍生物以及它们作为大麻素受体配体的用途
|
|
TW200633718A
(en)
*
|
2004-12-16 |
2006-10-01 |
Applied Research Systems |
Treatment of hepatitis c in the asian population
|
|
MX2007009313A
(es)
|
2005-02-01 |
2007-09-12 |
Wyeth Corp |
Amino-piridinas como inhibidores de ????-secretasa.
|
|
BRPI0606902A2
(pt)
|
2005-02-14 |
2009-07-28 |
Wyeth Corp |
composto; método para o tratamento de uma doença ou distúrbio associado a atividade excessiva de bace em um paciente que dele necessite; método para modular a atividade de bace; composição farmacêutica
|
|
GB2438802A
(en)
|
2005-02-28 |
2007-12-05 |
Univ Rockefeller |
Structure of the hepatitis C virus NS5A protein
|
|
US8143288B2
(en)
|
2005-06-06 |
2012-03-27 |
Bristol-Myers Squibb Company |
Inhibitors of HCV replication
|
|
PE20070099A1
(es)
|
2005-06-30 |
2007-02-06 |
Janssen Pharmaceutica Nv |
N-heteroarilpiperazinil ureas como moduladores de la amida hidrolasa del acido graso
|
|
WO2007011284A1
(en)
|
2005-07-15 |
2007-01-25 |
Astrazeneca Ab |
Therapeutic agents
|
|
JP2009519342A
(ja)
|
2005-12-12 |
2009-05-14 |
ジェネラブズ テクノロジーズ インコーポレーティッド |
Ｎ−（６員芳香環）−アミド抗ウイルス化合物
|
|
RU2008128453A
(ru)
|
2005-12-12 |
2010-01-20 |
Дженелабс Текнолоджис, Инк. (Us) |
Соединение n-(5-членных арил)-амидов, фармацевтическая композиция с противовирусной активностью на их основе, способ лечения или профилактики вирусной инфекции с их помощью и способ их получения
|
|
EP1963276B9
(en)
|
2005-12-21 |
2012-09-26 |
Decode Genetics EHF |
N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation
|
|
CN102702194A
(zh)
|
2005-12-21 |
2012-10-03 |
雅培制药有限公司 |
抗病毒化合物
|
|
US7915411B2
(en)
|
2005-12-21 |
2011-03-29 |
Abbott Laboratories |
Anti-viral compounds
|
|
US7910595B2
(en)
|
2005-12-21 |
2011-03-22 |
Abbott Laboratories |
Anti-viral compounds
|
|
WO2007082554A1
(en)
|
2006-01-23 |
2007-07-26 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Modulators of hcv replication
|
|
SG10201407457UA
(en)
|
2006-05-16 |
2014-12-30 |
Pharmascience Inc |
Iap bir domain binding compounds
|
|
JP2007320925A
(ja)
|
2006-06-02 |
2007-12-13 |
Mitsubishi Chemicals Corp |
トリアリールアミン系化合物並びにそれを用いた電子写真感光体及び画像形成装置
|
|
CA2652385A1
(en)
|
2006-06-08 |
2007-12-21 |
Eli Lilly And Company |
Novel mch receptor antagonists
|
|
CA2654097A1
(en)
|
2006-06-16 |
2007-12-21 |
Syngenta Limited |
Ethenyl carboxamide derivatives useful as microbiocides
|
|
US20100056495A1
(en)
|
2006-07-24 |
2010-03-04 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
WO2008014238A2
(en)
|
2006-07-24 |
2008-01-31 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
US7759495B2
(en)
|
2006-08-11 |
2010-07-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US7659270B2
(en)
|
2006-08-11 |
2010-02-09 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US20100158862A1
(en)
|
2006-08-11 |
2010-06-24 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US8329159B2
(en)
|
2006-08-11 |
2012-12-11 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8303944B2
(en)
|
2006-08-11 |
2012-11-06 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US7745636B2
(en)
|
2006-08-11 |
2010-06-29 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US20100055071A1
(en)
|
2006-11-21 |
2010-03-04 |
Martin Robert Leivers |
Anti-Viral Compounds
|
|
JP2010510246A
(ja)
|
2006-11-21 |
2010-04-02 |
スミスクライン ビーチャム コーポレーション |
アミド抗ウイルス化合物
|
|
US8236950B2
(en)
|
2006-12-20 |
2012-08-07 |
Abbott Laboratories |
Anti-viral compounds
|
|
WO2008074450A2
(en)
|
2006-12-20 |
2008-06-26 |
Nicox S.A. |
Non-peptidic renin inhibitors nitroderivatives
|
|
WO2008128121A1
(en)
|
2007-04-12 |
2008-10-23 |
Joyant Pharmaceuticals, Inc. |
Smac mimetic dimers and trimers useful as anti-cancer agents
|
|
US7741347B2
(en)
*
|
2007-05-17 |
2010-06-22 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8173696B2
(en)
|
2007-06-13 |
2012-05-08 |
Baylor University |
Inhibitors of cysteine proteases and methods of use thereof
|
|
US20090004140A1
(en)
|
2007-06-26 |
2009-01-01 |
Yao-Ling Qiu |
4-substituted pyrrolidine as anti-infectives
|
|
MX2010001400A
(es)
|
2007-08-03 |
2010-04-22 |
Schering Corp |
Metodo para tratar enfermedades mediadas cxcr3 usando piperazinas heterociclicas sustituidas.
|
|
US7728027B2
(en)
|
2007-08-08 |
2010-06-01 |
Bristol-Myers Squibb Company |
Process for synthesizing compounds useful for treating hepatitis C
|
|
US8629171B2
(en)
|
2007-08-08 |
2014-01-14 |
Bristol-Myers Squibb Company |
Crystalline form of methyl ((1S)-1-((25)-2-(5-(4'-(2-((25)-1((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt
|
|
GB0801199D0
(en)
|
2008-01-23 |
2008-02-27 |
Acal Energy Ltd |
Fuel cells
|
|
US9029411B2
(en)
|
2008-01-25 |
2015-05-12 |
Millennium Pharmaceuticals, Inc. |
Thiophenes and uses thereof
|
|
KR20100123717A
(ko)
|
2008-02-12 |
2010-11-24 |
브리스톨-마이어스 스큅 컴퍼니 |
Ｃ형 간염 바이러스 억제제로서의 헤테로시클릭 유도체
|
|
HRP20120440T1
(hr)
|
2008-02-12 |
2012-06-30 |
Bristol-Myers Squibb Company |
Inhibitori virusa hepatitisa c
|
|
US7704992B2
(en)
|
2008-02-13 |
2010-04-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
PL2242752T3
(pl)
|
2008-02-13 |
2012-12-31 |
Bristol Myers Squibb Co |
Imidazolilobifenyloimidazole jako inhibitory wirusa zapalenia wątroby typu c
|
|
US8147818B2
(en)
|
2008-02-13 |
2012-04-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
CN101959506A
(zh)
|
2008-02-28 |
2011-01-26 |
雅培制药有限公司 |
片剂和其制备方法
|
|
WO2009136290A1
(en)
|
2008-05-05 |
2009-11-12 |
Aegera Therapeutics, Inc. |
Functionalized pyrrolidines and use thereof as iap inhibitors
|
|
WO2009143361A1
(en)
|
2008-05-22 |
2009-11-26 |
Smithkline Beecham Corporation |
Amido anti-viral compounds
|
|
AU2009261919A1
(en)
|
2008-06-27 |
2009-12-30 |
Pharmascience Inc. |
Bridged secondary amines and use thereof as IAP BIR domain binding compounds
|
|
ME02024B
(me)
|
2008-07-22 |
2015-05-20 |
Merck Sharp & Dohme |
Makrociklična jedinjenja hinoksalina kao inhibitori hcv ns3 proteaze
|
|
CA2730448A1
(en)
|
2008-08-02 |
2010-02-11 |
Genentech, Inc. |
Inhibitors of iap
|
|
US20120009141A1
(en)
|
2008-08-07 |
2012-01-12 |
Pharmascience Inc. |
Functionalized pyrrolidines and use thereof as iap inhibitors
|
|
US7906655B2
(en)
|
2008-08-07 |
2011-03-15 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
UY32099A
(es)
*
|
2008-09-11 |
2010-04-30 |
Enanta Pharm Inc |
Inhibidores macrocíclicos de serina proteasas de hepatitis c
|
|
US8383094B2
(en)
|
2008-10-01 |
2013-02-26 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8946289B2
(en)
|
2008-11-19 |
2015-02-03 |
Duke University |
Manassatin compounds and methods of making and using the same
|
|
JP2010126571A
(ja)
|
2008-11-26 |
2010-06-10 |
Toyo Ink Mfg Co Ltd |
有機エレクトロルミネッセンス素子材料および有機エレクトロルミネッセンス素子
|
|
US8729077B2
(en)
|
2008-11-28 |
2014-05-20 |
Glaxosmithkline Llc |
Anti-viral compounds, compositions, and methods of use
|
|
EP2774927A1
(en)
|
2008-12-03 |
2014-09-10 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of HCV NS5A
|
|
BRPI0922366B8
(pt)
|
2008-12-03 |
2021-05-25 |
Presidio Pharmaceuticals Inc |
composto, composição farmacêutica e uso de um composto
|
|
WO2010075376A2
(en)
|
2008-12-23 |
2010-07-01 |
Abbott Laboratories |
Anti-viral compounds
|
|
WO2010075380A1
(en)
|
2008-12-23 |
2010-07-01 |
Abbott Laboratories |
Anti-viral compounds
|
|
WO2010091413A1
(en)
|
2009-02-09 |
2010-08-12 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
|
US8314135B2
(en)
|
2009-02-09 |
2012-11-20 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole antivirals
|
|
US8188132B2
(en)
|
2009-02-17 |
2012-05-29 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
|
TWI438200B
(zh)
|
2009-02-17 |
2014-05-21 |
必治妥美雅史谷比公司 |
Ｃ型肝炎病毒抑制劑
|
|
US8637561B2
(en)
|
2009-02-17 |
2014-01-28 |
Enanta Pharmaceuticals, Inc. |
Linked diimidazole derivatives
|
|
US8242156B2
(en)
|
2009-02-17 |
2012-08-14 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
|
US8394968B2
(en)
|
2009-02-17 |
2013-03-12 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
WO2010096462A1
(en)
|
2009-02-17 |
2010-08-26 |
Enanta Pharmaceuticals, Inc |
Linked diimidazole derivatives
|
|
US8420686B2
(en)
|
2009-02-17 |
2013-04-16 |
Enanta Pharmaceuticals, Inc. |
Linked diimidazole antivirals
|
|
WO2010094977A1
(en)
|
2009-02-23 |
2010-08-26 |
Arrow Therapeutics Limited |
Novel biphenyl compounds useful for the treatment of hepatitis c
|
|
WO2010096777A1
(en)
|
2009-02-23 |
2010-08-26 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
|
US8673954B2
(en)
|
2009-02-27 |
2014-03-18 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
|
US8101643B2
(en)
|
2009-02-27 |
2012-01-24 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
|
US8426458B2
(en)
|
2009-02-27 |
2013-04-23 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C Virus inhibitors
|
|
ES2606717T3
(es)
|
2009-02-27 |
2017-03-27 |
Enanta Pharmaceuticals, Inc. |
Inhibidores del virus de la hepatitis C
|
|
US8507522B2
(en)
|
2009-03-06 |
2013-08-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
MX2011010132A
(es)
|
2009-03-27 |
2011-10-14 |
Presidio Pharmaceuticals Inc |
Inhibidores de anillo fusionado de hepatitis c.
|
|
CN102427729B
(zh)
|
2009-03-27 |
2014-09-03 |
默沙东公司 |
丙型肝炎病毒复制的抑制剂
|
|
US8709999B2
(en)
|
2009-03-27 |
2014-04-29 |
Presidio Pharmaceuticals, Inc. |
Substituted bicyclic HCV inhibitors
|
|
US8796466B2
(en)
|
2009-03-30 |
2014-08-05 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
TWI476190B
(zh)
|
2009-03-30 |
2015-03-11 |
必治妥美雅史谷比公司 |
Ｃ型肝炎病毒抑制劑
|
|
US20110237636A1
(en)
|
2009-03-30 |
2011-09-29 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US9067942B2
(en)
|
2009-04-08 |
2015-06-30 |
Basf Se |
Pyrrolopyrrole derivatives, their manufacture and use as semiconductors
|
|
TW201038559A
(en)
|
2009-04-09 |
2010-11-01 |
Bristol Myers Squibb Co |
Hepatitis C virus inhibitors
|
|
US8143414B2
(en)
|
2009-04-13 |
2012-03-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
EP2419404B1
(en)
|
2009-04-15 |
2015-11-04 |
AbbVie Inc. |
Anti-viral compounds
|
|
CA2759142A1
(en)
|
2009-04-24 |
2010-10-28 |
Tibotec Pharmaceuticals |
Diaryl ethers
|
|
US9139569B2
(en)
|
2009-05-12 |
2015-09-22 |
Merck Sharp & Dohme Corp. |
Fused tricyclic aryl compounds useful for the treatment of viral diseases
|
|
RS56654B8
(sr)
|
2009-05-13 |
2021-06-30 |
Gilead Pharmasset Llc |
Antiviralna jedinjenja
|
|
US8138215B2
(en)
|
2009-05-29 |
2012-03-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8772505B2
(en)
|
2009-05-29 |
2014-07-08 |
Merck Sharp & Dohme Corp. |
Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis C
|
|
US8211928B2
(en)
|
2009-05-29 |
2012-07-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
CA2763140A1
(en)
|
2009-05-29 |
2010-12-02 |
Schering Corporation |
Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
|
|
US8937150B2
(en)
|
2009-06-11 |
2015-01-20 |
Abbvie Inc. |
Anti-viral compounds
|
|
US9394279B2
(en)
|
2009-06-11 |
2016-07-19 |
Abbvie Inc. |
Anti-viral compounds
|
|
EA020031B1
(ru)
|
2009-06-11 |
2014-08-29 |
Эббви Бахамаз Лтд. |
Противовирусные соединения
|
|
WO2010148006A1
(en)
|
2009-06-16 |
2010-12-23 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
|
US8221737B2
(en)
|
2009-06-16 |
2012-07-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8609648B2
(en)
|
2009-07-02 |
2013-12-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
WO2011004276A1
(en)
|
2009-07-06 |
2011-01-13 |
Pfizer Limited |
Hepatitis c virus inhibitors
|
|
EP2454254A2
(en)
|
2009-07-16 |
2012-05-23 |
Vertex Pharmaceuticals Incorporated |
Benzimidazole analogues for the treatment or prevention of flavivirus infections
|
|
EP2462135A1
(en)
|
2009-08-07 |
2012-06-13 |
Janssen R&D Ireland |
Bis-benzimidazole derivatives as hepatitis c virus inhibitors
|
|
RU2012112824A
(ru)
|
2009-09-03 |
2013-10-10 |
Тиботек Фармасьютикалз |
Производные бис-бензимидазола
|
|
EP2473056A4
(en)
|
2009-09-04 |
2013-02-13 |
Glaxosmithkline Llc |
CHEMICAL COMPOUNDS
|
|
US8815928B2
(en)
|
2009-09-11 |
2014-08-26 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US9156818B2
(en)
|
2009-09-11 |
2015-10-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8703938B2
(en)
|
2009-09-11 |
2014-04-22 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8927709B2
(en)
|
2009-09-11 |
2015-01-06 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8759332B2
(en)
|
2009-09-11 |
2014-06-24 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
EP2475254A4
(en)
|
2009-09-11 |
2013-05-22 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
|
US8822700B2
(en)
|
2009-09-11 |
2014-09-02 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
WO2011050146A1
(en)
|
2009-10-23 |
2011-04-28 |
Glaxosmithkline Llc |
Chemical compounds
|
|
UA108211C2
(uk)
|
2009-11-04 |
2015-04-10 |
Янссен Рід Айрленд |
Бензімідазолімідазольні похідні
|
|
US20110269956A1
(en)
|
2009-11-11 |
2011-11-03 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US20110274648A1
(en)
|
2009-11-11 |
2011-11-10 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US20110281910A1
(en)
|
2009-11-12 |
2011-11-17 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
AU2010324871A1
(en)
|
2009-11-25 |
2012-06-14 |
Merck Sharp & Dohme Corp. |
Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
|
|
TWI429645B
(en)
|
2009-12-04 |
2014-03-11 |
|
Proline derivatives
|
|
US8653070B2
(en)
|
2009-12-14 |
2014-02-18 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8377980B2
(en)
|
2009-12-16 |
2013-02-19 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
WO2011075607A1
(en)
|
2009-12-18 |
2011-06-23 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
|
SG181797A1
(en)
|
2009-12-18 |
2012-07-30 |
Idenix Pharmaceuticals Inc |
5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
|
|
CA2785488A1
(en)
|
2009-12-22 |
2011-07-21 |
Merck Sharp & Dohme Corp. |
Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases
|
|
US20130072523A1
(en)
|
2009-12-24 |
2013-03-21 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
|
US8362020B2
(en)
|
2009-12-30 |
2013-01-29 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
WO2011091446A1
(en)
|
2010-01-22 |
2011-07-28 |
Glaxosmithkline Llc |
Chemical compounds
|
|
CN102843909A
(zh)
|
2010-01-25 |
2012-12-26 |
埃南塔制药公司 |
丙型肝炎病毒抑制剂
|
|
JP2013518062A
(ja)
|
2010-01-28 |
2013-05-20 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｃ型肝炎阻害化合物
|
|
US8178531B2
(en)
|
2010-02-23 |
2012-05-15 |
Enanta Pharmaceuticals, Inc. |
Antiviral agents
|
|
CN102858157A
(zh)
|
2010-03-04 |
2013-01-02 |
埃南塔制药公司 |
作为hcv复制的抑制剂的组合药物活性剂
|
|
EP2545060B1
(en)
|
2010-03-09 |
2015-11-25 |
Merck Sharp & Dohme Corp. |
Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases
|
|
MX2012010918A
(es)
|
2010-03-24 |
2013-01-18 |
Vertex Pharma |
Analogos para el tratamiento o prevencion de infecciones por flavivirus.
|
|
TW201141857A
(en)
|
2010-03-24 |
2011-12-01 |
Vertex Pharma |
Analogues for the treatment or prevention of flavivirus infections
|
|
TW201139438A
(en)
|
2010-03-24 |
2011-11-16 |
Vertex Pharma |
Analogues for the treatment or prevention of flavivirus infections
|
|
WO2011119870A1
(en)
|
2010-03-24 |
2011-09-29 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
|
WO2011127350A1
(en)
|
2010-04-09 |
2011-10-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
|
US20110312996A1
(en)
|
2010-05-17 |
2011-12-22 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
|
WO2011150243A1
(en)
|
2010-05-28 |
2011-12-01 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
|
US8778938B2
(en)
|
2010-06-04 |
2014-07-15 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
TW201201801A
(en)
|
2010-06-09 |
2012-01-16 |
Presidio Pharmaceuticals Inc |
Inhibitors of HCV NS5A protein
|
|
NZ605440A
(en)
|
2010-06-10 |
2014-05-30 |
Abbvie Bahamas Ltd |
Solid compositions comprising an hcv inhibitor
|
|
WO2012040389A2
(en)
|
2010-09-22 |
2012-03-29 |
Presidio Pharmaceuticals, Inc. |
Substituted bicyclic hcv inhibitors
|
|
CA2812699A1
(en)
|
2010-09-24 |
2012-03-29 |
Bristol-Myers Squibb Company |
Hepatitis c virus inhibitors
|
|
WO2012040923A1
(en)
|
2010-09-29 |
2012-04-05 |
Merck Sharp & Dohme Corp. |
Tetracyclic indole derivatives and methods of use thereof for the treatment of viral diseases
|
|
TWI471670B
(zh)
|
2010-09-29 |
2015-02-01 |
Au Optronics Corp |
液晶顯示面板
|
|
US20130280214A1
(en)
|
2010-09-29 |
2013-10-24 |
Merck Sharp & Dohme Corp. |
Polycyclic heterocycle derivatives and methods of use thereof for the treatment of viral diseases
|
|
EP2621279B1
(en)
|
2010-09-29 |
2018-04-04 |
Merck Sharp & Dohme Corp. |
Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
|
|
BR112013007696A2
(pt)
|
2010-09-29 |
2019-09-24 |
Merck Sharp & Dohme |
composto, composição farmacêutica, usos do referido composto e da referida composição
|
|
WO2012041227A1
(en)
|
2010-09-29 |
2012-04-05 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds for treating hepatitis c viral infection
|
|
WO2012040924A1
(en)
|
2010-09-29 |
2012-04-05 |
Merck Sharp & Dohme Corp. |
Fused tetracyclic heterocycle compounds and methods of use thereof for treatment of viral diseases
|
|
US8921372B2
(en)
|
2010-11-04 |
2014-12-30 |
Theravance Biopharma R&D Ip, Llc |
Inhibitors of hepatitis C virus
|
|
WO2012068234A2
(en)
|
2010-11-17 |
2012-05-24 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
RU2452735C1
(ru)
|
2010-11-30 |
2012-06-10 |
Александр Васильевич Иващенко |
Замещенные азолы, противовирусный активный компонент, фармацевтическая композиция, способ получения и применения
|
|
WO2012087976A2
(en)
|
2010-12-21 |
2012-06-28 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|